{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T07:56:07Z","timestamp":1767167767677,"version":"build-2238731810"},"reference-count":11,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,3,10]]},"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:p>Sympathetic paragangliomas are rare neuroendocrine tumours that arise from chromaffin cells and secrete catecholamines. On rare occasions, patients with sympathetic paragangliomas can present with symptoms of congestive heart failure. The optimal treatment is surgical to remove all disease and thereby improve survival as well as restore cardiac function. We report a case of a patient with a regional metastatic bladder paraganglioma and a succinate dehydrogenase complex subunit B gene mutation presenting with cardiomyopathy who had significant improvement in his cardiac function with surgical resection despite further progression of metastatic disease. During his 4-year follow-up period, the patient remains free from heart-failure signs and symptoms.<\/jats:p>","DOI":"10.1136\/bcr-2019-233731","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T05:34:26Z","timestamp":1584596066000},"page":"e233731","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Regional metastatic paraganglioma of the bladder: a rare cause of myocardial infarction, reversible cardiomyopathy and an intracardiac thrombus"],"prefix":"10.1136","volume":"13","author":[{"given":"Vera","family":"Kazakova","sequence":"first","affiliation":[{"name":"Department of Medicine, St Elizabeth's Medical Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Kadamkulam Syriac","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology, Dana Farber Cancer Institute at St Elizabeth's Medical Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandr","family":"Perepletchikov","sequence":"additional","affiliation":[{"name":"Pathology, St Elizabeth's Medical Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann T","family":"Sweeney","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, St Elizabeth's Medical Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"key":"2025082703453546000_13.3.e233731.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-007-9360-4"},{"key":"2025082703453546000_13.3.e233731.2","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0b013e3181a6de40"},{"key":"2025082703453546000_13.3.e233731.3","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002198","article-title":"Acute and chronic Pheochromocytoma-Induced cardiomyopathies: different prognoses?: a systematic analytical review","volume":"94","author":"Batisse-Lignier","year":"2015","journal-title":"Medicine"},{"key":"2025082703453546000_13.3.e233731.4","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2012-101192"},{"key":"2025082703453546000_13.3.e233731.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.8.943"},{"key":"2025082703453546000_13.3.e233731.6","doi-asserted-by":"publisher","DOI":"10.4158\/EP11327.OR"},{"key":"2025082703453546000_13.3.e233731.7","doi-asserted-by":"publisher","DOI":"10.1139\/Y09-042"},{"key":"2025082703453546000_13.3.e233731.8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijcard.2017.07.014","article-title":"Pheochromocytoma as a reversible cause of cardiomyopathy: analysis and review of the literature","volume":"249","author":"Zhang","year":"2017","journal-title":"Int J Cardiol"},{"key":"2025082703453546000_13.3.e233731.9","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-214134","article-title":"Phaeochromocytoma presenting with ST segment elevation myocardial infarction","volume":"2016","author":"Ahmed","year":"2016","journal-title":"BMJ Case Rep"},{"key":"2025082703453546000_13.3.e233731.10","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-214737","article-title":"Phaeochromocytoma presenting as an acute coronary syndrome","volume":"2016","author":"Imam","year":"2016","journal-title":"BMJ Case Rep"},{"key":"2025082703453546000_13.3.e233731.11","doi-asserted-by":"crossref","unstructured":"Mulla CM , Marik PE . Pheochromocytoma presenting as acute decompensated heart failure reversed with medical therapy. BMJ Case Rep 2012;2012. doi:doi:10.1136\/bcr-2012-006319. [Epub ahead of print: 19 Jul 2012].","DOI":"10.1136\/bcr-2012-006319"}],"updated-by":[{"DOI":"10.1136\/bcr-2019-233731corr1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000}}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-233731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:45:44Z","timestamp":1756291544000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-233731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":11,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,18]]},"published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1136\/bcr-2019-233731"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-233731","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}